rs281865361
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000330.4(RS1):c.625C>T(p.Arg209Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R209H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000330.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RS1 | NM_000330.4 | c.625C>T | p.Arg209Cys | missense_variant | 6/6 | ENST00000379984.4 | NP_000321.1 | |
RS1 | XM_047442337.1 | c.529C>T | p.Arg177Cys | missense_variant | 4/4 | XP_047298293.1 | ||
CDKL5 | NM_001037343.2 | c.2714-3953G>A | intron_variant | NP_001032420.1 | ||||
CDKL5 | NM_003159.3 | c.2714-3953G>A | intron_variant | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RS1 | ENST00000379984.4 | c.625C>T | p.Arg209Cys | missense_variant | 6/6 | 1 | NM_000330.4 | ENSP00000369320.3 | ||
CDKL5 | ENST00000379989.6 | c.2714-3953G>A | intron_variant | 1 | ENSP00000369325.3 | |||||
CDKL5 | ENST00000379996.7 | c.2714-3953G>A | intron_variant | 1 | ENSP00000369332.3 | |||||
RS1 | ENST00000476595.1 | n.1116C>T | non_coding_transcript_exon_variant | 5/5 | 1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:3Other:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2015 | The R209C variant has been reported previously in association with X-linked retinoshcisis including several extended families ( Hayashi et al., 2004; Hewitt et al., 2005; Lesch et al., 2008; Kim et al. 2009; Retinoschisis Consortium 1998). The R209C variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R209C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. - |
not provided, no classification provided | literature only | Retina International | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 10, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 209 of the RS1 protein (p.Arg209Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with retinoschisis (PMID: 9618178, 28272453, 30652005). ClinVar contains an entry for this variant (Variation ID: 99006). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RS1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
Juvenile retinoschisis Pathogenic:2
Likely pathogenic, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | May 31, 2018 | This variant is interpreted as a Likely Pathogenic, for Retinoschisis juvenile X-linked 1, in X-linked Recessive manner. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PS4-Moderate => PS4 downgraded in strength to Moderate (PMID:16272055,19093009,15531314,28272453,19390641,15932525). PM5 => Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before. PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PP1 => Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (PMID:15531314). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Nov 14, 2016 | - - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at